“The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men With Obesity and Insulin Resistance”. 2026. Global Scientific Review 48 (February): 42-45. https://scienticreview.com/index.php/gsr/article/view/602.